The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Human pharmacology of a performance‐enhancing dietary supplement under resting and exercise conditions
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Performance‐enhancing dietary supplements have not been clinically tested for safety or efficacy. • In clinical trials performed under resting conditions, performance‐enhancing supplements raise blood pressure and affect glucose homeostasis. • The effect of exercise on the pharmacokinetics and pharmacodynamics of stimulant herbals is unknown. WHAT THIS STUDY ADDS • Supplement‐induced effects on blood pressure and glucose levels are not ameliorated by exercise. • Exercise does not affect the kinetics of stimulant ingredients, caffeine and synephrine. • Performance‐enhancing supplement use modestly improves exercise tolerance. AIMS: Dietary supplements (DS) promoted to enhance athletic performance often contain herbal sympathomimetics such as Citrus aurantium (synephrine) and caffeine. We aimed to characterize the pharmacology of a performance‐enhancing DS in the setting of exercise. METHODS: Ten healthy adults (three women) aged 20–31 years participated in a three‐arm, double‐blind, placebo‐controlled, crossover study. Subjects ingested one dose of DS (Ripped Fuel Extreme Cut® with 21 mg synephrine and 304 mg caffeine by analysis) under resting conditions and 1 h prior to moderately intense exercise (30 min on cycle ergometer at 75–80% HR max), with a placebo (PLC)/exercise control. Plasma synephrine and caffeine concentrations were measured over 12 h, and vital signs, serum electrolytes, oxygen consumption and perceived exercise exertion were monitored. RESULTS: No significant adverse events occurred. Synephrine and caffeine pharmacokinetics were unaffected by exercise. Post‐exercise diastolic blood pressure was higher after DS (peak mean 71.7 ± 8.7 mmHg) than PLC (63.0 ± 4.9 mmHg) (p = 0.007). There were no substantial treatment‐related differences in post‐exercise HR, systolic blood pressure, or temperature. Postprandial plasma glucose increased to 121.0 ± 31.6 mg dl−1 with DS and exercise vs. 103.7 ± 25.5 mg dl−1 with PLC and exercise (P = 0.004). No treatment differences in exercise‐related oxygen consumption, serum lactate, or insulin were observed. Exercise was rated less difficult with DS than PLC (P = 0.001). CONCLUSIONS: Blood pressure and plasma glucose increased post‐exercise with DS use, which could be detrimental in some people. Exercise was perceived as less strenuous after DS, presumably due to the stimulant effects of caffeine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Self-citationCoffee Consumption and Risk of Type 2 Diabetes: A Systematic Review
van Dam, R. M., & Hu, F. B. (2005) · JAMA · doi:10.1001/jama.294.1.97 · Cited by 662
Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J. (2003) · JAMA · doi:10.1001/jama.289.12.1537 · Cited by 511
Metabolic and exercise endurance effects of coffee and caffeine ingestion
Graham, T. E., Hibbert, E., & Sathasivam, P. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.3.883 · Cited by 305 · cited 2×
“Previous studies on caffeine effects on glucose regulation are highly variable, with a few reports showing no effect of caffeine on glucose in the setting of exercise [ 17 , 18].”
BackgroundBattram, D. S., Arthur, R., Weekes, A., & Graham, T. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.5.1276 · Cited by 135
Bell, D. G., Jacobs, I., & Zamecnik, J. (1998) · European Journal of Applied Physiology · doi:10.1007/s004210050355 · Cited by 96
Research works printed but not linked: 22
- Perrotta DM, 1996, Adverse events associated with ephedrine‐containing products – Texas, Dec. 1993 to Sept. 1995, JAMA, 276, 1711, 10.1001/jama.1996.03540210019010 · DOI
- Bell DG, 1999, Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test, Aviat Space Environ Med, 70, 325
- 10.1097/00005768-200202000-00024 · DOI
- 10.1097/00005768-200108000-00024 · DOI · Paper page
- 10.1152/jappl.1991.71.6.2292 · DOI · Paper page
- Erikson MSA, 1987, Effects of caffeine, fructose and glucose ingestion on muscle glycogen utilization during exercise, Med Sci Sports Exerc, 19, 579
- 10.1210/jc.85.6.2170 · DOI
- 10.1007/s004210100456 · DOI
- Bell DG, 1999, Thermal regulation in the heat during exercise after caffeine and ephedrine ingestion, Aviat Space Environ Med, 70, 583
- 10.1249/00005768-198205000-00012 · DOI · Paper page
- 10.1016/j.amjmed.2005.02.034 · DOI
- 10.1152/jappl.2000.89.5.1837 · DOI
- 10.1152/jappl.1998.85.4.1493 · DOI · Paper page
- 10.2165/00003088-199019010-00003 · DOI
- 10.1152/jappl.2000.89.3.1079 · DOI
- 10.1055/s-2007-971976 · DOI · Paper page
- 10.1038/clpt.1983.172 · DOI
- 10.1152/japplphysiol.00762.2000 · DOI
- 10.3109/07853899109148066 · DOI
- 10.1093/ajcn/84.4.682 · DOI · Paper page
- Haller CA, 2005, Clin Pharmacol Ther, 560
- 10.1152/jappl.1998.85.4.1502 · DOI · Paper page
Cited by
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613
“The BfR (2012) reviewed human intervention studies investigating the acute effects of p-synephrine on blood pressure and heart rate, either alone (Min et al., 2005; Bui et al., 2006; Stohs et al., 2011) or in combination with caffeine (Haller et al., 2005b, 2008; Seifert et al., 2011).”
BackgroundStohs, S. J., Preuss, H. G., & Shara, M. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4446 · Cited by 115
Magalhães, L. M., de Oliveira, C. V. C., Gonçalves, M. D. C. R., de Souza, A. A., & Silva, A. S. (2013) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2013.03.02.3 · Cited by 1
“On the other hand, when 304mg of caffeine plus 21 mg of synephrine of the commercial supplement Ripped Fuel Extreme Cut ® was used, the subjects showed significant higher diastolic blood pressure compared to placebo group, but not systolic blood pressure [20].”
Method
Metadata
- Authors
- Haller, C. A., Duan, M., Jacob, P., & Benowitz, N.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2008-04-03
- Volume
- 65
- Issue
- 6
- Pages
- 833-840
- ISSN
- 0306-5251
- 1365-2125
- Cited by
- 56
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human pharmacology of a performance‐enhancing dietary supplement under resting and exercise conditions. https://app.cochat.ai/papers/10.1111/j.1365-2125.2008.03144.x
- The paper
- Haller, C. A., Duan, M., Jacob, P., & Benowitz, N. (2008). Human pharmacology of a performance‐enhancing dietary supplement under resting and exercise conditions. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2008.03144.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.